Checkmate Pharmaceuticals, Inc.: accounts_payable
| Value | {"amount": 3608000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-03-31) |
| Status | current |
| Entity | Checkmate Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cc126c3f-8a50-4f1c-9cab-3a86c14cf38f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-148774 · Open the official SEC filing →Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001651431/accounts-payable/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cc126c3f-8a50-4f1c-9cab-3a86c14cf38f
History
- no predecessors — first report